267 related articles for article (PubMed ID: 30566253)
1. Omentin-1 level in adolescents with polycystic ovarian syndrome.
Özgen İT; Oruçlu Ş; Selek S; Kutlu E; Guzel G; Cesur Y
Pediatr Int; 2019 Feb; 61(2):147-151. PubMed ID: 30566253
[TBL] [Abstract][Full Text] [Related]
2. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
3. Plasma omentin-1 levels are reduced in non-obese women with normal glucose tolerance and polycystic ovary syndrome.
Choi JH; Rhee EJ; Kim KH; Woo HY; Lee WY; Sung KC
Eur J Endocrinol; 2011 Nov; 165(5):789-96. PubMed ID: 21865408
[TBL] [Abstract][Full Text] [Related]
4. Examination of angiopoietin-like protein 4, neuropeptide Y, omentin-1 levels of obese and non-obese patients with polycystic ovary syndrome.
Güneş M; Bukan N
Gynecol Endocrinol; 2015; 31(11):903-6. PubMed ID: 26291814
[TBL] [Abstract][Full Text] [Related]
5. Relationship among plasma adipokines, insulin and androgens level as well as biochemical glycemic and lipidemic markers with incidence of PCOS in women with normal BMI.
Akbarzadeh S; Ghasemi S; Kalantarhormozi M; Nabipour I; Abbasi F; Aminfar A; Jaffari SM; Motamed N; Movahed A; Mirzaei M; Rahbar AR
Gynecol Endocrinol; 2012 Jul; 28(7):521-4. PubMed ID: 22309615
[TBL] [Abstract][Full Text] [Related]
6. Circulating anti-Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome.
Olszanecka-Glinianowicz M; Madej P; Owczarek A; Chudek J; Skałba P
Clin Endocrinol (Oxf); 2015 Jul; 83(1):98-104. PubMed ID: 25440474
[TBL] [Abstract][Full Text] [Related]
7. Circulating omentin-1 levels in women with polycystic ovary syndrome: a meta-analysis.
Tang YL; Yu J; Zeng ZG; Liu Y; Liu JY; Xu JX
Gynecol Endocrinol; 2017 Mar; 33(3):244-249. PubMed ID: 27908216
[TBL] [Abstract][Full Text] [Related]
8. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
9. Plasma omentin and adiponectin levels as markers of adipose tissue dysfunction in normal weight and obese women with polycystic ovary syndrome.
Orlik B; Madej P; Owczarek A; Skałba P; Chudek J; Olszanecka-Glinianowicz M
Clin Endocrinol (Oxf); 2014 Oct; 81(4):529-35. PubMed ID: 24392647
[TBL] [Abstract][Full Text] [Related]
10. Serum omentin-1 levels in obese children.
Zengi S; Zengi O; Kirankaya A; Kucuk SH; Kutanis EE; Yigit O
J Pediatr Endocrinol Metab; 2019 Mar; 32(3):247-251. PubMed ID: 30817300
[TBL] [Abstract][Full Text] [Related]
11. Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome.
Guzel EC; Celik C; Abali R; Kucukyalcin V; Celik E; Guzel M; Yilmaz M
Gynecol Endocrinol; 2014 Jun; 30(6):419-22. PubMed ID: 24524360
[TBL] [Abstract][Full Text] [Related]
12. Circulating omentin-1 levels and inflammation in polycystic ovary syndrome.
Franik G; Sadlocha M; Madej P; Owczarek A; Skrzypulec-Plinta V; Plinta R; Chudek J; Olszanecka-Glinianowicz M
Ginekol Pol; 2020; 91(6):308-312. PubMed ID: 32627151
[TBL] [Abstract][Full Text] [Related]
13. An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients.
Liao Y; Huang R; Sun Y; Yue J; Zheng J; Wang L; Tao T; Ma J; Li S; Liu W
Reprod Biol Endocrinol; 2017 Jan; 15(1):9. PubMed ID: 28125989
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of serum level of omentin-1 in females with hirsutism.
Kenawi MZ; Akl EM; Sabry JH; Mostafa ST
J Cosmet Dermatol; 2020 Feb; 19(2):535-539. PubMed ID: 31190433
[TBL] [Abstract][Full Text] [Related]
15. Low omentin-1 levels are related with clinical and metabolic parameters in obese children.
Catli G; Anik A; Abaci A; Kume T; Bober E
Exp Clin Endocrinol Diabetes; 2013 Nov; 121(10):595-600. PubMed ID: 24085389
[TBL] [Abstract][Full Text] [Related]
16. Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome.
Guvenc Y; Var A; Goker A; Kuscu NK
J Int Med Res; 2016 Aug; 44(4):796-805. PubMed ID: 27225862
[TBL] [Abstract][Full Text] [Related]
17. Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome.
Kort DH; Kostolias A; Sullivan C; Lobo RA
Gynecol Endocrinol; 2015 Feb; 31(2):152-5. PubMed ID: 25295622
[TBL] [Abstract][Full Text] [Related]
18. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M
Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the pro-inflammatory cytokine tumor necrosis factor-α in adolescents with polycystic ovary syndrome.
Pawelczak M; Rosenthal J; Milla S; Liu YH; Shah B
J Pediatr Adolesc Gynecol; 2014 Dec; 27(6):356-9. PubMed ID: 25256873
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome.
Alemzadeh R; Kichler J; Calhoun M
Eur J Endocrinol; 2010 Jun; 162(6):1093-9. PubMed ID: 20371657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
